1 Result(s)

Article

Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies

Biosimilar CT-P13 was approved with limited data from clinical trials compared to the originator infliximab in biologic-naïve patients with rheumatoid arthritis. Three prospective post-marketing surveillance s...

Tsutomu Takeuchi, Kiyohiro Nishikawa, Fumika Yamada, Akimichi Morita… in Drug Safety (2023)